mRNA-based influenza vaccine expands breadth of B cell response in humans
Hanover Matz(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Anders Madsen(University of Bergen), Fangjie Han(Guangzhou University), Julian Q. Zhou(AbCellera (Canada)), Mark J. Hoegger(Mallinckrodt (United States)), Rachel M. Presti(Johns Hopkins University), Stephen Horváth(Washington University in St. Louis), Aaron J. Schmitz(Washington University in St. Louis), Kritika Dixit(Washington University in St. Louis), William D. Middleton(Mallinckrodt (United States)), Lowrey Peyton(Dartmouth College), Jackson S. Turner(Washington University in St. Louis), Robert Paris(GlaxoSmithKline (United States)), Michael K. Klebert(Washington University in St. Louis), Hunter K. Keplinger(Washington University in St. Louis), Jiwon Lee(Dartmouth College), Nina H. Lin(Moderna Therapeutics (United States)), Benjamin S. Strnad(Mallinckrodt (United States)), Tae-Geun Yu(Dartmouth College), Raffael Nachbagauer(Moderna Therapeutics (United States))
Cited by 4
Related Papers
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851